Featured Articles
Latest Articles
Article
From Clinical Implications to Modernizing Regulatory Frameworks: Noteworthy Advances To Watch in Cell and Gene Therapy R&D
Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several points of progress in CGT R&D worth watching are discussed.
Article
Top Tips for Going Paperless in the Lab
Technology Networks spoke with Dr. Samantha Pearman-Kanza to learn more about the benefits (and potential pitfalls) of going paperless in the lab and some of the research advancing digital technologies.
Article
Claiming Space in STEMM: An Interview With Hazel X. Ang
Dr. Hazel X. Ang shares their experiences navigating STEMM, reflecting on progress, remaining barriers and the everyday actions that make research environments more inclusive.
Article
Building Inclusive Cultures in STEMM: An Interview With Dr. Tyler Brown
Dr. Tyler Brown discusses his experiences of working in STEMM and highlights how the industry can foster a more inclusive workplace culture.
Article
Bringing Your Whole Self to the Lab: An Interview With Max Fisher
Queer scientist Max Fisher shares insights on identity, inclusion and the simple changes that help create safer, more supportive lab spaces for LGBTQIA+ researchers.
Article
Data Compliance: Can AI Help Users Navigate New Technologies and Regulations?
AI tools are reshaping how labs handle compliance, from automating audit trails to improving data reuse and accuracy. In this article, we examine how the rise of AI is transforming compliance and how users can stay informed.
Article
Embracing Environmentally Friendly Practices in the Research Lab
How can research labs reduce their environmental impact? Technology Networks asked two sustainability experts to find out.
Article
Will Labs Wake Up to the Environmental Cost of Data Crunching?
The rise of digital science is reshaping lab sustainability. In this article, experts highlight the need for new standards to account for computing’s growing environmental impact.
Article
How Close Is MDMA to Becoming a Psychiatric Treatment?
Once dismissed as a party drug, MDMA is reemerging as a therapeutic option for treatment-resistant PTSD. Dr. Kenji Hashimoto explores MDMA’s neurobiological, gut–brain and vagus nerve effects while outlining safety, regulatory and clinical questions.
Advertisement